CSTL

Castle Biosciences Inc. Common Stock

HealthcareDiagnostics & ResearchNASDAQ

$24.93

-2.33%today

MKT CAP

$748M

+2.3% · 1Y

Full Financials

Trailing P/E-

Forward P/E-

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ-

5y Revenue CAGR-

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership-

Institutional Ownership-

Short % of Float-

Days to Cover-

1 Week+1.5%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
OPK OPKO Health Inc. Common Stock	$853M	5	-	-	-	-	-	-	0.00%
PSNL Personalis Inc. Common Stock	$628M	-	-	-	-	-	-	-	0.00%
WGS GeneDx Holdings Corp. Class A Common Stock	$998M	60	-	19.7	-	-	-	-	0.00%
CDNA CareDx Inc. Common Stock	$1.1B	60	-	18.3	-	-	-	-	0.00%
NEO NeoGenomics Inc. Common Stock	$1.2B	40	-	24.4	-	-	-	-	0.00%
FLGT Fulgent Genetics Inc. Common Stock	$426M	-	-	-	-	-	-	-	0.00%